trending Market Intelligence /marketintelligence/en/news-insights/trending/038o7vlllhii23egk9gdjq2 content esgSubNav
In This List

Cytori Therapeutics falls out of compliance with Nasdaq listing requirements

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Cytori Therapeutics falls out of compliance with Nasdaq listing requirements

Cytori Therapeutics Inc. said it fell out of compliance with the Nasdaq Stock Market LLC's listing requirements.

The Nasdaq said in a notice that the San Diego-based company failed to maintain a minimum bid price of $1 per share for the last 30 consecutive business days.

Cytori Therapeutics has until Feb. 25, 2019, to regain compliance with the listing requirement, the company said in an SEC filing.

The company had recently regained compliance with Nasdaq's minimum bid price rule after implementing a 1-for-10 reverse stock split.